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IntroductIon
Stroke is the most common cause of long-term disability 
in the Western world. Evidence is beginning to emerge 
that fatigue after stroke is a common problem and that it 
is distressing to patients. Recent studies have found that 
between 30–68% of patients after stroke have fatigue1 and 
one study2 found that 40% of patients rated their fatigue 
as among the worst of their symptoms following stroke. 
Fatigue can cause increased difficulty taking part in 
physical therapy.1 Despite the impact of fatigue after 
stroke, little research has been done in this area. There are 
many potential causes of fatigue following stroke, such as 
physical de-conditioning, metabolic co-morbidities or 
depression, but currently the aetiology of fatigue remains 
uncertain.3 Animal studies have shown an association 
between pro-inflammatory cytokines and altered 
behavioural processes called ‘sickness behaviour’, which 
include reduced social behaviour, altered sleep patterns 
and increased sensitivity to pain.4 Thus, it is plausible that 
in humans cytokines may also induce a ‘sickness behaviour’ 
which may include symptoms of fatigue. 
Fatigue associated with other conditions has been much 
more extensively studied than post-stroke fatigue. The 
high prevalence rate and disabling effects of fatigue 
following cancer chemotherapy have led to much 
interest in this field.5–7 In particular, an association 
between pro-inflammatory cytokines and fatigue has 
been demonstrated in several studies.5–7 There is also 
preliminary evidence of an association between fatigue 
and inflammation following colorectal surgery8 and in 
multiple sclerosis.9
After acute stroke, there is evidence of systemic 
inflammation. C-reactive protein (CRP) levels are higher 
in patients with more severe strokes,10 and higher CRP 
is associated with worse outcome10,11 after correcting for 
stroke severity. The pro-inflammatory cytokine inter-
leukin 6 (IL-6) is released in acute stroke. Interleukin 6 
levels correlate with brain infarct volume and outcome12 
and predict clinical deterioration early after ischaemic 
stroke.13 To our knowledge, the relationship between 
systemic inflammation after stroke and fatigue has not 
been studied.
A pilot observational study of the association 
between fatigue after stroke and C-reactive protein 
ABStrAct 
Background: The aetiology of fatigue after stroke is unknown. We explored the 
relationship between fatigue and C-reactive protein (CRP) as a marker of 
inflammation. 
Methods: This cross-sectional study recruited inpatients with a stroke (onset 
within the previous three months) over a five-week period. Those with dysphasia 
or confusion severe enough to prevent informed consent and those with current 
infection were excluded.  A semi-structured interview determined a) fulfilment of 
a case definition for fatigue and b) severity of fatigue (fatigue assessment scale, 
FAS). Venous blood was taken for CRP.  A hospital anxiety and depression score 
(HADS) was used to screen for emotional distress.
Results: Of the 28 patients recruited (mean age 72.7 years, proportion men 47%), 
15 (53%) fulfilled the case definition for fatigue. C-reactive protein data were 
logarithmically transformed for analysis. C-reactive protein levels did not differ 
significantly between those with and without fatigue, according to the case definition 
(n=28, p=0.35).  After exclusion of those with pre-stroke fatigue and those with high 
scores on the HADS (suggestive of emotional distress), the geometric mean CRP 
of the fatigued group was 16.04 mg/l (95% CI: 7.12–36.14) compared with 5.16 mg/l 
(95% CI: 2.7–9.85) in the non-fatigued group (n=21, p=0.025, unpaired t test), 
but the relationship between FAS and CRP was not statistically significant (r=0.37, 
p= 0.098).
Conclusion: This pilot study is the first to demonstrate an association between 
fatigue after stroke and higher CRP, after excluding patients with pre-stroke fatigue 
and those with probable mood disorders. If this finding is confirmed in a larger 
number of patients, it might provide a target for treating fatigue after stroke.
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Because of the increasing amount of evidence implicating 
inflammation in fatigue in conditions other than stroke,5–9 
our aim was to collect data about the relationship between 
fatigue after stroke and inflammation (as measured by CRP) 
in a small group of patients with stroke, in order to inform 
power calculations for a larger study. 
MethodS
Recruitment and initial information gathered 
Patients were recruited between 23 March 2009 and 30 
April 2009.  Any inpatient on one of three stroke units was 
potentially eligible to participate, providing they had 
suffered a stroke within the previous three months. 
Patients known to have an active infection, those with 
white cell counts of >10 x 109/l and/or currently receiving 
antibiotics and those with confusion or dysphasia severe 
enough to impair ability to give informed consent were 
excluded. Those with known malignancy and those with 
inflammatory disease such as rheumatoid arthritis were 
also excluded. The researcher, Fiona McKechnie, was 
introduced to potentially eligible patients by the medical 
team. She provided the patients with information about 
the study, and each patient was given up to 24 hours to 
consider whether to participate. Demographic data were 
extracted from the inpatient medical records of consenting 
patients, including age, date of stroke and pathological 
type of stroke (haemorrhagic or ischaemic). 
Assessment of fatigue
Firstly, the researcher confirmed that the participants 
were aware of the meaning of fatigue, asked whether they 
had experienced fatigue prior to their stroke, and then 
performed a semi-structured, face-to-face interview to 
determine whether they fulfilled a case definition for 
clinically significant fatigue.14 The definition of fatigue was: 
‘Since their stroke the patient has experienced fatigue, a 
lack of energy or an increased need to rest every day or 
nearly every day.’ To fulfil the case definition for fatigue, 
patients needed to have fatigue (rather than boredom or 
reduced motivation) for >50% of waking hours, and this 
fatigue had to have been present every day or nearly 
every day since their stroke. This fatigue had to have led 
to difficulty taking part in everyday activities (for inpatients, 
this included any physical therapy). This definition had 
been developed based on patients’ description of fatigue, 
and had been tested for reliability.14
Patients were then asked to complete the fatigue 
assessment scale (FAS). This was chosen as it is feasible, 
valid and reliable in patients who have had a stroke.15 The 
scale consists of ten questions about aspects of fatigue, 
each rated on a five-point scale from ‘never’ to ‘always’.16 
This scale was applied to all patients irrespective of 
whether they fulfilled the case definition for fatigue.
The hospital anxiety and depression score (HADS) 
was then administered to screen for emotional 
distress (including depression and anxiety), which might 
cause fatigue.17 
Laboratory analyses 
Immediately following the completion of the ques-
tionnaires, a venous blood sample was taken. This was 
sent to the routine biochemistry laboratory, via the 
usual hospital transport system, for analysis. C-reactive 
protein was assayed using a Latex-enhanced immuno-
turbidimetric method on an automated Olympus 
AU2700 analyser, according to the manufacturer’s 
protocol. The published analytical sensitivity of the assay 
is 0.14 mg/l, with reported intra-assay and inter-assay 
coefficients of variation of 3.22% and 3.8% respectively 
at a CRP concentration of 6.6 mg/l. 
Statistical analysis
All data were entered into SPSS Version 13.0. The FAS was 
normally distributed. C-reactive protein was normally 
distributed after log10 transformation. All these 
distributions were tested using the Shapiro-Wilk test of 
normality.  All analyses were therefore carried out with 
the log10 transformed CRP data and the raw FAS data. 
An unpaired t-test was used to compare the levels of 
CRP between patients with and without fatigue 
(according to the case definition). The relationship 
between log10 transformed CRP and the FAS was 
analysed using Pearson’s correlation coefficient.
We included the whole group in our initial analyses, and 
then excluded those with pre-stroke fatigue and those 
with high scores on the HADS, suggestive of emotional 
distress. 
As this was a pilot study, we did not perform power 
calculations; rather, the purpose of the study was to gain 
data to inform power calculations for a larger study.   
reSultS 
Thirty-one patients were eligible to participate. Of 
these, three patients declined (two did not want an 
additional blood sample to be taken, one did not feel 
physically well enough). Of the 28 patients included, the 
mean age was 73 years (SD=14.1) and 15 (54%) were 
female. Twenty-six had had an ischaemic stroke and two 
a haemorrhagic stroke. The median time between stroke 
onset and interview was 35 days (range 3–89 days). Four 
patients stated that they had suffered from fatigue 
before their stroke. Of the 28 patients included in the 
study, 15 (53%) fulfilled the case definition for clinically 
significant fatigue. 
The geometric mean CRP was 8.03 mg/l (95% CI: 3.86–
16.71) in the fatigued group (n=15), compared with 
5.16 mg/l (95% CI: 2.7–9.85) without fatigue (n=13). This 
difference was not statistically significant (p=0.35, 
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unpaired t-test). There was no significant correlation 
between FAS and log10 CRP levels (r=0.12, p=0.55).
We performed further analyses by excluding those four 
patients who reported pre-stroke fatigue. The geometric 
mean CRP in the fatigued group (n=11) was 9.43 (95% 
CI: 3.98–22.36) compared with 5.16 (95% CI: 2.7–9.85) 
in the non-fatigued group (n=13, p=0.22). There was no 
significant correlation between log10 CRP and FAS 
(r=0.09, p=0.67). 
We then excluded the three patients who scored highly 
on the HADS (28, 28 and 30 respectively), as their 
fatigue may have been a result of emotional distress. Of 
the eight remaining patients fulfilling the case definition, 
the geometric mean CRP was 16.04 (95% CI: 7.12–
36.14), compared with 5.16 (95% CI: 2.7–9.85) in the 13 
patients not fulfilling the case definition. This difference 
between groups was statistically significant (p=0.025). 
However, there was no significant correlation between 
log10 CRP and FAS (r=0.37, p=0.098).  Figure 1 shows 
the distribution of FAS scores and log10 CRP levels.  
dIScuSSIon
This is the first study to our knowledge to explore the 
relationship between fatigue and CRP after stroke.  Around 
half of patients fulfilled our case definition for fatigue 
following stroke, which is similar to the findings of previous 
studies.1 Although CRP levels were higher in patients 
fulfilling the case definition compared with those who did 
not, this relationship was not statistically significant. However, 
when patients with high scores on the HADS (suggestive of 
mood disorders) and those with pre-stroke fatigue were 
excluded, CRP levels were significantly higher in patients 
fulfilling the case definition for fatigue.  
This study has a number of limitations. The main one is 
that the sample size was small. This was a student project 
so the time to recruit patients was constrained by the 
time available (5.5 weeks). Secondly, the study focused 
on inpatients who generally would have had more severe 
strokes than outpatients, thus limiting the external 
validity of the results. Thirdly, patients were enrolled at 
different time points after the onset of their stroke 
(range 3–89 days). Thus, this study provided only a 
‘snapshot’ of the relationship between fatigue and 
inflammation and we cannot infer direction of causality; 
that is, does inflammation cause fatigue or does fatigue 
cause inflammation? 
Additionally, it is known that both fatigue and CRP levels 
are not stable throughout the first three months 
following stroke. Future studies should therefore 
measure CRP at a fixed time point after stroke. Fourthly, 
because this was a small study, we did not correct for 
other factors that might be associated with fatigue: for 
example, a recent study found a relationship between 
systemic hypotension and fatigue.3 
Other factors that could influence CRP levels were not 
recorded. Drugs such as lipid-lowering therapies or 
angiotensin-converting enzyme inhibitors are commonly 
used in stroke patients and can affect CRP levels. These 
factors were not recorded in this study as it was 
primarily a student project and had been designed to 
keep analysis as simple as possible. Future studies should 
take into account the effect of drugs as confounding 
factors on CRP levels. Also, the severity of the stroke 
could influence the level of CRP and so may have an 
influence on fatigue. A larger study would need to take 
into account the relationship between inflammation, 
fatigue and stroke severity. Finally, CRP is only one 
measure of inflammation; future studies might also 
measure other inflammatory cytokines. 
In conditions other than stroke, where there is a 
relationship between fatigue and inflammation, the 
mechanisms are thought to be complex. In cancer-
related fatigue, pro-inflammatory cytokines may cause 
the fatigue by signalling the central nervous system to 
induce sleep and other ‘sickness behaviours’.5 It has been 
shown that higher levels of IL-6, a pro-inflammatory 
cytokine that is produced during inflammatory processes, 
causes a change in the pattern of sleep and increased 
levels of fatigue.5 Alterations in circulating levels of this 
and other pro-inflammatory cytokines have also been 
noted in fatigue relating to other conditions, such as 
depression18 and chronic fatigue syndrome.19 The 
physiological role of pro-inflammatory cytokines in the 
development of fatigue is, however, very complicated and 
poorly understood. Fatigue is a complex multidimensional 
symptom which is likely to be influenced by a variety of 
factors, and therefore a single cause is unlikely.
The next step is to explore the association between CRP 
and fatigue in a much larger cohort of patients. The data 
from this pilot study have informed power calculations for 
such a larger cohort study. If larger studies do confirm a 
relationship between inflammation and fatigue after 
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FiguRe 1 Relationship between fatigue assessment scale 
and transformed C-reactive protein levels in all 28 patients.
FAS
log10 CRP
stroke, this might provide a target for treatment. Given 
that there is currently no effective treatment for fatigue 
after stroke, a better understanding of its aetiology is key 
to the development of new therapies.20,21 
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